Answers are grounded in this paper and cite their sources.
L-ascorbic acid (vitamin C) is an essential antioxidant molecule that maintains normal physiological functions in humans. Currently, industrial production relies primarily on a three-strain, two-step fermentation process to produce 2-keto-L-gulonic acid (2-KLG), the direct precursor of vitamin C. 2-KLG is then converted to vitamin C through chemical lactonization. However, this process is limited by prolonged fermentation cycles, poor stability of the mixed-culture system, and complex process control. In recent years, engineered single-strain platforms capable of one-step 2-KLG biosynthesis have emerged as a promising strategy for more sustainable vitamin C production. Nevertheless, the efficiency of L-sorbose-to-2-KLG conversion in this system remains low, making it a major bottleneck to further improving 2-KLG production. This review summarizes recent advances on single-strain, one-step fermentation systems using Gluconobacter oxydans as the chassis strain. It focuses on strategies including genetic tool development, metabolic engineering, and key enzyme optimization. The review aims to provide a theoretical basis and technical reference for optimizing and industrializing green biomanufacturing systems for vitamin C.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: